Poly(ADP-ribose) polymerase-1 and its ambiguous role in cellular life and death

被引:5
|
作者
Castedo, Maria [1 ,2 ]
Lafarge, Antoine [1 ,2 ,3 ]
Kroemer, Guido [1 ,2 ,4 ]
机构
[1] Sorbonne Univ, Univ Paris Cite, Ctr Rech Cordeliers, Equipe 11 Labellisee Ligue Canc,INSERM U1138, F-75006 Paris, France
[2] Metabol & Cell Biol Platforms, Gustave Roussy Canc Campus, Villejuif, France
[3] Univ Paris Saclay, Fac medecine, Le Kremlin Bicetre, France
[4] Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Inst Canc Paris CARPEM, Dept Biol, Paris, France
关键词
PARP1; inhibition; DNA damage; parthanatos; cancer; neurological diseases; aging; cellular stress response; PARP; INHIBITION; NECROSIS; MITOCHONDRIAL; ACTIVATION; CISPLATIN; APOPTOSIS; ELEGANS;
D O I
10.15698/cst2023.01.275
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The deletion of the gene coding for poly(ADP-ribose) polymerase-1 (PARP1) or its pharmacological inhi-bition protects mice against cerebral ischemia and Parkin-son's disease. In sharp contrast, PARP1 inhibitors are in clinical use for the eradication of vulnerable cancer cells. It appears that excessive PARP1 activation is involved in a specific cell death pathway called parthanatos, while inhi-bition of PARP1 in cancer cells amplifies DNA damage to a lethal level. Hence, PARP1 plays a context-dependent role in cell fate decisions. In addition, it appears that PARP1 plays an ambiguous role in organismal aging.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 50 条
  • [31] Cleavage of poly (ADP-ribose) polymerase-1 is involved in the process of porcine ovarian follicular atresia
    Wei, Quanwei
    Shi, Fangxiong
    ANIMAL REPRODUCTION SCIENCE, 2013, 138 (3-4) : 282 - 291
  • [32] Caffeine metabolites are inhibitors of the nuclear enzyme poly(ADP-ribose)polymerase-1 at physiological concentrations
    Geraets, Liesbeth
    Moonen, Harald J. J.
    Wouters, Emiel F. M.
    Bast, Aalt
    Hageman, Geja J.
    BIOCHEMICAL PHARMACOLOGY, 2006, 72 (07) : 902 - 910
  • [33] Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: An update
    C. Soldani
    A. I. Scovassi
    Apoptosis, 2002, 7 : 321 - 328
  • [34] Poly(ADP-Ribose) Polymerase-1 in Lung inflammatory Disorders: A Review
    Sethi, Gurupreet S.
    Dharwal, Vivek
    Naura, Amarjit S.
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [35] Inhibition of poly(ADP-ribose)polymerase-1 and DNA repair by uranium
    Cooper, Karen L.
    Dashner, Erica J.
    Tsosie, Ranalda
    Cho, Young Mi
    Lewis, Johnnye
    Hudson, Laurie G.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2016, 291 : 13 - 20
  • [36] Poly(ADP-ribose)polymerase-1 hyperactivation in neurodegenerative diseases: The death knell tolls for neurons
    Narne, Parimala
    Pandey, Vimal
    Simhadri, Praveen Kumar
    Babu, Phanithi Prakash
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2017, 63 : 154 - 166
  • [37] Oxidative stress initiates DNA damager MNNG-induced poly(ADP-ribose)polymerase-1-dependent parthanatos cell death
    Chiu, Ling-Ya
    Ho, Feng-Ming
    Shiah, Shine-Gwo
    Chang, Yung
    Lin, Wan-Wan
    BIOCHEMICAL PHARMACOLOGY, 2011, 81 (03) : 459 - 470
  • [38] Ischemic preconditioning by caspase cleavage of poly(ADP-ribose) polymerase-1
    Garnier, P
    Ying, WH
    Swanson, RA
    JOURNAL OF NEUROSCIENCE, 2003, 23 (22) : 7967 - 7973
  • [39] Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: An update
    Soldani, C
    Scovassi, AI
    APOPTOSIS, 2002, 7 (04) : 321 - 328
  • [40] Multiple facets of poly(ADP-ribose) polymerase-1 in neurological diseases
    Chandra Shaker Sriram
    Ashok Jangra
    Rajaram Mohanrao Madhana
    Satendra Singh Gurjar
    Pritam Mohan
    Babul Kumar Bezbaruah
    NeuralRegenerationResearch, 2015, 10 (01) : 49 - 51